First in Human Study of TORL-3-600 in Participants With Advanced Cancer
First in Human Study of TORL-3-600 in Participants With Advanced Cancer
Active, not recruiting · NCT05948826 · Registry updated 2025-10-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Study of TORL-3-600 in Participants With Advanced Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 1 | 2025-10-10 | NCT05948826 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TORL Biotherapeutics, LLC | 8 |
| Translational Research in Oncology | 9 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fort Wayne Medical Oncology and Hematology Inc. | Fort Wayne | United States | 1 |
| Mary Crowley Cancer Research | Dallas | United States | 29 |
| McGill University Health Centre | Montreal | Canada | 69 |
| Providence Medical Foundation | Fullerton | United States | 46 |
| Sarah Cannon Research Institute | Denver | United States | 16 |
| Sarah Cannon Research Institute-Tennessee | Nashville | United States | 1 |
| UCLA - JCCC Clinical Research Unit | Los Angeles | United States | 6 |
| University Health Network, Princess Margaret Cancer Centre | Toronto | Canada | 12 |
| Washington University School OF Medicine-Siteman Cancer Center | St Louis | United States | 4 |